Chemical Formula | C21H17F2N5O6 |
Molecular Weight | 475.38 |
Iupac Name | (4R,12aS)-N-(2,4-difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide |
Physical State | Solid (predicted, based on similar compounds) |
Melting Point | No data available |
Boiling Point | No data available |
Chemical Name | (4R,12aS)-N-(2,4-difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide |
Stereochemistry | 4R,12aS |
Functional Groups | hydroxy, carboxamide, dioxo, pyrido-pyrazino-oxazine |
What is the chemical structure of (4R, 12aS) -N- (2,4-difluorobenzyl) -7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido [1 ', 2': 4,5] pyrazino [2,1-b] [1,3] oxazine-9-formamide
This organic compound has a complex naming and contains many groups and spatial configuration information. It is explained in the classical Chinese style of "Tiangong Kaiwu", and its meaning is as follows:
Looking at this compound, it has a specific spatial configuration, shown by (4R, 12aS), which is the symbol of spatial atomic arrangement. Its main structure contains fused heterocycles, which are like pavilions, with quinolino [1 ', 2': 4,5] pyridino [2,1 - b] [1,3] oxazine as the base, interlocking and exquisite structure.
On the main structure, many groups are attached. The N-position is connected with 2,4-difluorophenyl. The introduction of fluorine atoms, such as adding a unique decoration to the pavilion, affects the properties of the compound. The 7-position is connected with methoxy group, and the 4-position has methyl group. Although the two are small, they are like tenon and mortise pieces, which subtly adjust the overall characteristics. The 6,8-position is dioxy, which is like the windows and windows of the pavilion, giving it a different reactivity.
Furthermore, the compound contains 3,4,6,8,12,12a-hexahydro, indicating that there is hydrogen atom addition on some rings, which seems to be a different building locally. The 9-position is connected with methanesulfonamide group, such as a delicate attachment outside the pavilion, which further affects the physical and chemical properties of the compound. < Br >
Such a complex structure, the interaction of various groups, such as the synergy of building components, co-structures this unique organic compound, with unique characteristics and potential in the field of chemistry.
What are the main uses of (4R, 12aS) -N- (2,4-difluorobenzyl) -7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido [1 ', 2': 4,5] pyrazino [2,1-b] [1,3] oxazine-9-formamide
(4R, 12aS) -N- (2,4-difluorophenyl) -7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyridino [1 ', 2': 4,5] pyridino [2,1-b] [1,3] oxazine-9-formamide, which is an important compound in the field of new drug development. Its main uses are quite extensive, and it is often studied as a potential antifungal drug in the field of medicine. Numerous studies have shown that it has significant inhibitory effects on specific fungi, or can bring new opportunities for the treatment of fungal infections.
To observe the way of medicine in the world, curing diseases and saving people is the top priority. This medicine has been studied by many prescriptions and is expected to become a good agent to deal with the ravages of fungi. Nowadays, fungal infections occur from time to time, and patients are miserable. If this medicine can come out, it will be like the rain of a long drought, saving all people from the pain. Therefore, many doctors and pharmacists have devoted their efforts to studying its pharmacology, hoping to use it in clinical practice as soon as possible and benefit the common people.
What is the preparation method of (4R, 12aS) -N- (2,4-difluorobenzyl) -7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido [1 ', 2': 4,5] pyrazino [2,1-b] [1,3] oxazine-9-formamide
To prepare (4R, 12aS) -N- (2,4-difluorophenyl) -7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyridino [1 ', 2': 4,5] pyridino [2,1-b] [1,3] oxazine-9-formamide, the method is as follows:
First take an appropriate amount of raw materials with specific reactivity, add a suitable solvent to a clean reactor, and disperse the raw materials evenly. Pay attention to the characteristics of the solvent, its polarity, boiling point, etc. have a great impact on the reaction process. < Br >
Then, slowly add a precisely measured catalyst. This catalyst is the key to the reaction, and its dosage and activity are all related to the yield and purity of the product. When adding, the speed should be slow, and it needs to be stirred constantly to ensure that the catalyst is fully integrated with the raw material.
After that, carefully adjust the reaction temperature and pressure. If the temperature is too high, it may cause side reactions; if the temperature is too low, the reaction rate will be slow. Pressure also needs to be precisely controlled, and it is complementary to the temperature to create the most suitable reaction environment.
During the reaction process, regular monitoring is required. Either using chromatography or spectroscopy to gain insight into the progress of the reaction, the consumption of raw materials, and the generation of products.
When the reaction approaches the end point, the product is separated from the reaction system by suitable separation methods, such as filtration, extraction, distillation, etc. Then through meticulous purification steps, impurities are removed and the purity of the product is improved. In this way, high purity of (4R, 12aS) -N- (2,4-difluorophenyl) -7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyridino [1 ', 2': 4,5] pyridino [2,1-b] [1,3] oxazine-9-formamide can be obtained.
What are the pharmacological activities of (4R, 12aS) -N- (2,4-difluorobenzyl) -7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido [1 ', 2': 4,5] pyrazino [2,1-b] [1,3] oxazine-9-formamide?
(4R, 12aS) -N- (2,4-difluorophenyl) -7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyridino [1 ', 2': 4,5] pyrimido [2,1-b] [1,3] oxazine-9-formamide compounds, with a variety of pharmacological activities. In the field of anti-tumor, it can inhibit the proliferation of tumor cells, block their cycles and induce apoptosis by interfering with key metabolic pathways or signal transduction pathways of tumor cells, such as inhibiting lung cancer and breast cancer cells. In terms of antibacterial, it can destroy bacterial cell wall synthesis or interfere with nucleic acid metabolism, resist Gram-positive and negative bacteria, etc., and reduce the risk of infection. In the field of immunomodulation, it can regulate the activity of immune cells and factor secretion, correct immune imbalance, and treat autoimmune diseases. Some of these compounds also have neuroprotective potential, reduce nerve damage and inflammation, and are beneficial for the prevention and treatment of neurodegenerative diseases such as Parkinson's and Alzheimer's disease. However, in the development and application of such compounds, attention needs to be paid to efficacy, safety and side effects. After in-depth research and optimization, they can give full play to their pharmacological value and bring new hope for disease treatment.
What are the market prospects for (4R, 12aS) -N- (2,4-difluorobenzyl) -7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido [1 ', 2': 4,5] pyrazino [2,1-b] [1,3] oxazine-9-formamide?
(4R, 12aS) - N - (2,4 - difluorophenyl) - 7 - methoxy - 4 - methyl - 6,8 - dioxo - 3,4,6,8,12,12a - hexahydro - 2H - pyridino [1 ', 2': 4,5] pyridino [2,1 - b] [1,3] oxazine - 9 - formamide This thing is in the market, what is the prospect? I will imitate "Tiangong Kaiwu" to answer this question in the format of ancient languages.
Now there are (4R, 12aS) -N- (2,4-difluorophenyl) -7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyridino [1 ', 2': 4,5] pyridino [2,1-b] [1,3] oxazine-9-formamide, which has been quite impressive since it entered the market. This is an exquisite product of organic synthesis and may have extraordinary potential in the field of pharmaceutical chemistry.
Looking at its chemical structure, the functional groups are cleverly connected, and the unique structure may make it have specific biological activity. In the way of pharmaceuticals, it can be used as a lead compound to develop new drugs to fight against various diseases, such as inflammation and tumors.
At present, the need for medicine is increasing, and it is eager for innovative drugs. If this compound is studied in depth, optimized and improved, in line with pharmacological standards, it may be able to gain a place in the market and benefit patients.
Furthermore, the progress of scientific research and the refinement of analytical technology can also help its performance exploration. Its mechanism of action and pharmacokinetics can be clarified, paving the way for its application. Although the market competition is intense, this compound is unique. With time and proper development, it will surely bloom and gain considerable prospects in the pharmaceutical market.